| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 06/06/2006 | US7056895 1-(3,4-dihydroxy-5-methylol-tetrahydrofur-2-yl),3-amidino-1H-1,2,4- triazoles; infections, infestations, autoimmune diseases; anticarcinogenic and -tumor agents; HIV, hepatitis C, human papilloma virus and giant cell arteritis |
| 06/06/2006 | US7056886 GLP-2 formulations |
| 06/06/2006 | US7056885 Fibroblast growth factor and nucleic acids encoding same |
| 06/06/2006 | US7056884 Reduced FK228 and use thereof |
| 06/06/2006 | US7056500 Polymer conjugates of opioid antagonists |
| 06/06/2006 | CA2457852C Multivesicular emulsion topical delivery systems |
| 06/06/2006 | CA2327723C Bicyclic hydroxamic acid derivatives |
| 06/01/2006 | WO2006058303A2 Modulators of muscarinic receptors |
| 06/01/2006 | WO2006058080A1 Treatment of inflammatory bowel disease |
| 06/01/2006 | WO2006057270A1 Nitrogeneous tricyclic compound |
| 06/01/2006 | WO2006056794A1 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy |
| 06/01/2006 | WO2006056013A1 Stabilized calcium phosphate complexes |
| 06/01/2006 | WO2006018185A8 Dihydropteridinones for the treatment of cancer diseases |
| 06/01/2006 | WO2005107752A3 Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin |
| 06/01/2006 | WO2003025542A3 Immune response associated proteins |
| 06/01/2006 | US20060117414 Fad4, Fad5, Fad5-2, and Fad6, novel fatty acid desaturase family members and uses thereof |
| 06/01/2006 | US20060116518 Novel phenanthridines |
| 06/01/2006 | US20060116516 2-[[4-[[[4-(Aminosulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-4-methyl-5-thiazolecarboxylic acid, ethyl ester; 4-Methyl-2-[[4-[[[4-(methylsulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-5-thiazolecarboxylic acid, ethyl ester; Antiinflammatory agents; rheumatic diseases |
| 06/01/2006 | US20060116388 CXCR3 antagonists |
| 06/01/2006 | US20060116379 Compounds exhibiting type X sPLA2 inhibiting effect |
| 06/01/2006 | US20060116378 e.g. 3-[4-(2-Methyl-3-phenyl-allyl)-piperazin-1-ylmethyl]-3a,4-dihydro-3H-2,5-dioxa-1,7-diaza-dicyclopenta[a,g]naphthalene; serotonine (5-HT) reuptake inhibitor, alpha 2-adrenoceptor antagonist; antidepressant, anxiolytic agent; Parkinson's disease, eating disorders, psychosis, obesity |
| 06/01/2006 | US20060115869 Uses of carbamoyl phosphate synthetas for the diagnosis of inflammatory diseases and sepsis |
| 06/01/2006 | US20060115813 Intracellular signaling molecules |
| 06/01/2006 | US20060115538 Calcium lactate and whey permeate for lowering the triglyceride level |
| 06/01/2006 | US20060115530 Gastric acid secretion inhibiting composition |
| 06/01/2006 | US20060115436 Enzyme containing composition, process of producing said composition and its use |
| 06/01/2006 | US20060115376 Irradiation in presence of stabilizer; preventing degradation |
| 06/01/2006 | DE19849107B4 Verfahren zur Entfernung von unerwünschten, endogen vorhandenen toxischen Alkaloiden aus Pflanzen oder aus pflanzlichen Zubereitungen A method for removing unwanted endogenously present toxic alkaloids from plants or herbal preparations |
| 06/01/2006 | DE102004057645A1 New substituted pteridine compounds, useful as phosphodiesterase 4 inhibitors for treating e.g. inflammatory diseases, cancer, asthma, ulcerative colitis, depression and schizophrenia |
| 06/01/2006 | DE102004057618A1 Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen Substituted pteridines for the treatment of inflammatory diseases |
| 06/01/2006 | CA2589439A1 Modulators of muscarinic receptors |
| 06/01/2006 | CA2589438A1 Treatment of inflammatory bowel disease |
| 06/01/2006 | CA2589270A1 Stabilized calcium phosphate complexes |
| 06/01/2006 | CA2589261A1 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy |
| 06/01/2006 | CA2579962A1 Glycine as a diet supplement for the treatment of health problems that result from underlying metabolic disorders |
| 05/31/2006 | EP1662007A1 Preventive or remedy for inflammatory bowel diseases containing anti-cd81 antibody as the active ingredient |
| 05/31/2006 | EP1661898A1 Bicyclic piperazine compound and use thereof |
| 05/31/2006 | EP1661889A1 Chemokine receptor antagonist and medical use thereof |
| 05/31/2006 | EP1661574A1 Beta-hydroxy short to medium chain fatty acid polymer |
| 05/31/2006 | EP1661562A1 Sphingolipids in treatment and prevention of steatosis |
| 05/31/2006 | EP1661557A1 Materials and methods for making improved micelle compositions |
| 05/31/2006 | EP1660117A2 Use of secretagogues like ghrelin in cancer cachexia and for stimulating appetite |
| 05/31/2006 | EP1660093A1 Ammonium salts of ornithine derivatives for treating inflammatory diseases |
| 05/31/2006 | EP1660084A2 Proton pump inhibitors for the treatment of lower abdominal disorders |
| 05/31/2006 | EP1660083A2 Stable pharmaceutical composition of rabeprazole |
| 05/31/2006 | EP1660074A1 7-carboxymethyloxy-3 , 4 , 5-trimethoxy flavone monohyd rate, the preparation method and uses thereof |
| 05/31/2006 | EP1660044A2 Composition comprising a zeolite compound for treatment of diseases |
| 05/31/2006 | EP1659885A1 Compositions and methods for the maintenance of oral health |
| 05/31/2006 | EP1419178B1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use |
| 05/31/2006 | EP1345922B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1328282B1 Efficient method for producing compositions enriched in anthocyanins |
| 05/31/2006 | EP1318997B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317449B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317444B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1268798B1 Anti-angiogenic properties of vascostatin and fragments or variants thereof |
| 05/31/2006 | EP1263467B1 Paste formulations comprising silica |
| 05/31/2006 | EP1235851B1 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 05/31/2006 | EP1212084B1 Method of separating rotavirus variants and live attenuated rotavirus vaccine |
| 05/31/2006 | EP1163238B1 Chemokine recpetor binding heterocyclic compounds |
| 05/31/2006 | EP0946501B1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 05/31/2006 | CN1780642A Remedy for diabetes |
| 05/31/2006 | CN1780635A Preventives or remedies for hepatopathy |
| 05/31/2006 | CN1780615A The use of azetidinecarboxamide derivatives in therapy. |
| 05/31/2006 | CN1778820A Recombinant VPAC2 receptor specific agonist RMBAY, its expression and use |
| 05/31/2006 | CN1778819A Recombinant VPAC2 receptor specific agonist RMROM, its expression and use |
| 05/31/2006 | CN1778816A Human cell surface membrane molecule and use thereof |
| 05/31/2006 | CN1778385A Chinese medicine for treating diarrhea |
| 05/31/2006 | CN1778379A Compound pearl grass oral liquid |
| 05/31/2006 | CN1778373A Health-care composition |
| 05/31/2006 | CN1778364A Colloidal ball for detoxication and anodyne |
| 05/31/2006 | CN1778351A Medicine composition for treating hepatitis B and chronic hepatitis |
| 05/31/2006 | CN1778348A Danshen freeze-drying injection for treating cardiovascular and cerebrovascular diseases and preparation thereof |
| 05/31/2006 | CN1778332A Medicine composition for preparing hepatic diseases and its use thereof |
| 05/31/2006 | CN1778314A Health-care medical wine for tonifying kidney-yang |
| 05/31/2006 | CN1778308A Use of picrorrhiza glycoside II in preparation of medicine for treating hepatitis B |
| 05/31/2006 | CN1778304A Poly-sima-ester capsules and its preparation |
| 05/31/2006 | CN1778301A Budesonide target-direction microball and preparation thereof |
| 05/31/2006 | CN1257986C The method of detecting mutant DSPP gene of hereditary opalescent dentin |
| 05/31/2006 | CN1257905C Compounds for inhibiting the release of inflammatory cytokines |
| 05/31/2006 | CN1257903C Quinic compound containing quaternary ammonium group and its preparation and medicine use |
| 05/31/2006 | CN1257894C Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 05/31/2006 | CN1257892C New indole derivatives with 5-HT6 receptor affinity |
| 05/31/2006 | CN1257742C Nourishing medicinal wine |
| 05/31/2006 | CN1257736C Sobering-up liver-protecting medicine composition for preventing chemical liver damage and its preparation process |
| 05/31/2006 | CN1257727C Medicine composition for treating gastric ulcer, stomachache and superficial gastritis and its preparation and use |
| 05/31/2006 | CN1257721C Medicine for treating chronic liver disease and preparation thereof |
| 05/31/2006 | CN1257717C Medicine for treating pertinacious porking diarrhea and its preparation method |
| 05/31/2006 | CN1257716C Application of wolfberry polyose in the preparation process of gastric ulcer treating medicine |
| 05/31/2006 | CN1257709C Tensicor freeze-drying formulation and its making method |
| 05/30/2006 | US7053215 For therapy of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes |
| 05/30/2006 | US7053214 Tryptase inhibitor; antiinflammatory agents |
| 05/30/2006 | US7053117 Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/30/2006 | US7053113 Mannich base prodrugs of 3-(pyrrol-2-yl-methylidene)-2-indolinone derivatives |
| 05/30/2006 | US7053108 Indoline compounds |
| 05/30/2006 | US7053103 A pyrazolo[3,4-B]pyridine derivatives; corticotropin releasing factor receptor antagonists; treating stress-related illnesses, mood disorders, eating disorders, stress-induced gastrointestinal dysfunctions, neurodegenerative diseases, and neuropsychiatric disorders |
| 05/30/2006 | US7053098 3,4-Dihydro-(1H) quinazolin-2-one compounds as CSBP/P38 kinase inhibitors |
| 05/30/2006 | US7053090 Antiinflammatory agents; antihistamines; skin disorders; antiarthritic agents; antidiabetic agents; autoimmune disease |
| 05/30/2006 | US7053088 Vanilloid receptor ligands and their use in treatments |
| 05/30/2006 | US7053082 Neuroprotectants for treating epilepsy, stroke, Parkinson's disease, multiple sclerosis or amyotropic lateral sclerosis; 5-(3-methyl-4-amino or nitro-phenyl)-1,3-dioxolo[4,5-h][2,3]benzodiazepine; AMPA/cainate antagonistic effect; chemical intermediates |
| 05/30/2006 | US7053057 Caspase inhibitors and uses thereof |